Emerging therapeutic options for atopic dermatitis: beyond TIMs.

Abstract

Atopic dermatitis (AD) is a chronic inflammatory skin disease that significantly impacts both patients and their families. Although current therapies provide relief of symptoms for most but not all patients, they do not prevent or eradicate the disease. In this new era of biological therapy, medications that precisely target the molecular mediators of inflammation are being developed at a rapid pace. These biologic agents have proven useful for treating many inflammatory illnesses, as well as providing insight into disease pathogenesis. In atopic dermatitis, these new therapies may prove highly useful to both treat and prevent the disease. In this review article, we briefly review the pathogenesis of AD to discuss current therapies and to introduce potential new treatments.

• Authors: Edward R Conner, Lisa A Beck
• Journal: Current allergy and asthma reports (Curr Allergy Asthma Rep) Vol. 6 Issue 4 Pg. 275-81 (Jul 2006) ISSN: 1529-7322 [Print] United States
• PMID: 16822379 (Publication Type: Journal Article, Review)

Chemical References

• Anti-Inflammatory Agents

Topics

• Anti-Inflammatory Agents (therapeutic use)
• Biological Therapy (methods, trends)
• Chronic Disease
• Dermatitis, Atopic (immunology, pathology, therapy)
• Humans
• Inflammation (immunology, pathology, therapy)